Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
2.620
-0.080 (-2.96%)
Jun 23, 2025, 11:57 AM - Market open
RCKT's stock price has decreased by -88.26% in the past year and price targets may not have had time to catch up.
Rocket Pharmaceuticals Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
$18.50
Upside
+606.11%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $12 → $5 | Strong Buy | Maintains | $12 → $5 | +90.84% | Jun 17, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $34 → $11 | Strong Buy | Maintains | $34 → $11 | +319.85% | Jun 3, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $32 → $9 | Strong Buy | Maintains | $32 → $9 | +243.51% | May 28, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $30 → $8 | Buy | Maintains | $30 → $8 | +205.34% | May 28, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $51 → $19 | Buy | Maintains | $51 → $19 | +625.19% | May 28, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $37 → $8 | Buy → Hold | Downgrades | $37 → $8 | +205.34% | May 28, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $46 → $17 | Strong Buy | Maintains | $46 → $17 | +548.85% | May 28, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $29 → $2.5 | Strong Buy → Hold | Downgrades | $29 → $2.5 | -4.58% | May 28, 2025 |
| Needham | Needham | Strong Buy → Hold Downgrades $42 | Strong Buy → Hold | Downgrades | $42 | +1,503.05% | May 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $20 → $30 | Buy | Maintains | $20 → $30 | +1,045.04% | May 16, 2025 |
| Wedbush | Wedbush | Buy Reiterates $32 | Buy | Reiterates | $32 | +1,121.37% | May 16, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $45 → $46 | Strong Buy | Maintains | $45 → $46 | +1,655.73% | May 16, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $52 → $51 | Buy | Maintains | $52 → $51 | +1,846.56% | May 12, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $36 → $34 | Strong Buy | Maintains | $36 → $34 | +1,197.71% | May 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $54 → $45 | Strong Buy | Maintains | $54 → $45 | +1,617.56% | May 9, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $45 → $44 | Buy | Maintains | $45 → $44 | +1,579.39% | May 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.